InvestorLens

NUVB — NUVATION BIO INC

Public company

Sign in to save5 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying NUVB?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
65
Institutional Conviction
Net distribution · 0 buying vs 0 selling last quarter
38
Macro Tailwind
Macro conditions are mixed for this sector
56
Why? — Evidence & Confidence ▾

No tracked investor changed their NUVB position last quarter. Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).

Supporting evidence
  • +5 tracked investors reported holding NUVB at their latest filing
  • +Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About NUVATION BIO INC (NUVB)

NUVATION BIO INC (NUVB) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by Stanley Druckenmiller (Duquesne Family Office), valued at $26M. Across recent filings, tracked investors recorded 3 new positions, 3 increased, 4 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in NUVB

55
/100
Mixed Activity
Added / Increased6
Reduced4
Exited1
BearishBullish
Crowded Trade Score™

How many top investors track NUVB

33
/100
Emerging Interest
5investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

NUVB Ownership Composition

How NUVATION BIO INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Macro
54% of tracked value
Institutions
5
tracked investors
Total Reported
$55M
combined 13F value
Types3
  • Macro53.5%
  • Multi-Strategy / Quant46.1%
  • Value & Distressed0.4%
Macro(2)
53.5%
Multi-Strategy / Quant(2)
46.1%
Value & Distressed(1)
0.4%

Tracked investors currently reporting NUVB

1 tracked investor has since exited this position — listed separately below.

  • Stanley DruckenmillerJun 30, 2026
    Duquesne Family Office
    Shares
    4.5M
    Value
    $25.8M
    % Portfolio
    0.49%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    8.3M
    Value
    $8.6M
    % Portfolio
    0.00%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    16M
    Value
    $16.7M
    % Portfolio
    0.00%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    3.5M
    Value
    $3.7M
    % Portfolio
    0.01%
  • David EinhornJun 30, 2026
    DME Capital Management, LP
    Shares
    35K
    Value
    $198.8K
    % Portfolio
    0.01%

Previously held NUVB

These investors reported NUVB in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Steve CohenPoint72 Asset Management19.6K$175.5KDec 31, 2025

Recent activity

Frequently asked questions

How many institutional investors hold NUVB?
5 tracked institutional investors disclosed a position in NUVB (NUVATION BIO INC) in their most recent 13F filing.
Who is the largest institutional holder of NUVB?
Stanley Druckenmiller, Duquesne Family Office, holds the largest disclosed position in NUVB, valued at $26M.
Did institutional ownership of NUVB increase or decrease?
Across recent 13F filings, tracked investors recorded 3 new positions, 3 increased, 4 reduced, and 1 fully exited NUVB.
Where does this NUVB ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.